Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Asia Pacific Prostate Cancer Conference /
Mechanisms of action and robotics in mCRPC

1st - 2nd Mar 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.03.14
Views: 2496
Rating:

Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China

Dr Anthony Ng Chi-Fai from the University of Hong Kong speaks to ecancer from the Academy for Cancer Education (ACE) 3rd Asia Pacific Prostate Cancer Conference (APPCC) in Shanghai. 

He first outlines the various mechanisms of action of the drugs currently used in mCRPC post-chemotherapy, explaining the various pathways that are being influenced by different agents. He then goes on to discuss the mechanisms of action of newer drugs being explored, e.g. TAK-700. Dr Chi-Fai also outlines the design and aims of a new study with enzalutamide.

He then focuses on the new radium class of therapies; how they work, in whom they might be used and how they might benefit patient care. Dr Chi-Fai comments on the sequencing of therapies, and how decisions on this can be made.

Finally, Dr Chi-Fai comments on which patients might benefit from robotic surgery, and what advances are currently being made in this regard.

This video is sponsored by an educational grant from Janssen Asia Pacific, pharmaceutical companies of Johnson & Johnson

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation